Team up with Labcyte to strengthen your discovery partnerships. Pharmaceutical companies and CRO partners who use Echo 500 ® series liquid handlers and the POD ™ 810 plate assembler improve productivity, reduce project costs and accelerate discovery.
As pharmaceutical R&D becomes more complex, costly and competitive, contract research organizations (CROs) are becoming increasingly important strategic partners for many pharmaceutical companies. Contract research is one of few biotechnology growth sectors in the current economic climate. 1
Labcyte solutions can help to ensure the success of these critical strategic partnerships. Seventeen of the top 20 pharmaceutical companies worldwide have standardized on the Echo liquid handling platform for compound management, assay development, screening and lead optimization programs. They have proven that our tipless, touchless acoustic droplet ejection (ADE) technology reduces false negatives, improves precision and accuracy, and minimizes consumables costs and waste. CROs can reap the same benefits to deliver better results and a stronger competitive edge for their partners and themselves.
-
Echo systems guarantee superior transfer volume precision.
-
Unparalleled software flexibility enables users to customize protocols on the fly, with no special programming expertise. CROs can easily and efficiently manage different project requirements for multiple partners.
-
Echo systems use no tips or wash liquid, saving consumables costs and minimizing hazardous waste.
-
POD systems come ready to use out of the box, so your partnerships can be productive immediately and deliver results sooner.
1
The Scientist, Aug 5 2009